63 13F filers hold it · +31 against the quarter before · shares held +168.4%
Holdings of 06/30
Health care sectorNasdaq
63 13F filers hold it · +31 against the quarter before · shares held +168.4%
Orbimed Advisors holds 4.8%
10/16 estimated earnings
13F filers: 63 · +31 since the quarter before · 06/30 holdings
Famous funds that held Spruce Biosciences in their latest 13F report.
| Fund | Value | Since the quarter before |
|---|---|---|
| Mirae Asset Global ETFS HoldingsSpruce Biosciences SPRB · 06/30 holdings | $67.6K | No quarter before |
| Holder | ||
|---|---|---|
| Orbimed Advisors08/14 | 4.8%132,200 sh | First report |
| ADAR1 Capital Management08/14 | 2.5%67,717 sh | −2.9pp |
| Citadel Advisors08/14 | 1.9%51,919 sh | −3.2pp |
| AWM Investment Company08/14 | 5.1%146,988 sh | First report |
| Integrated Core Strategies08/04 | 5.8%160,981 sh | −3.8pp |
| BlackRock07/30 | 6.8%187,836 sh | First report |
| Orin Hirschman07/27 | 9.1%250,000 sh | First report |
| Citadel Advisors05/15 | 5.1%70,065 sh | −1.4pp |
| Alyeska Investment Group05/15 | 4.49%61,670 sh | −1.3pp |
| Squadron Capital Management05/15 | 0.9%12,200 sh | −5.6pp |
| Wellington Management Group05/15 | 3.6%48,796 sh | −1.9pp |
| Ikarian Capital05/07 | 4.8%121,356 sh | −6.6pp |
| ExodusPoint Capital Management04/28 | 0.8%22,000 sh | First report |
| Integrated Core Strategies02/24 | 9.6%103,026 sh | First report |
| Carlyle Group02/18 | 4.7%50,893 sh | No earlier report |
| ADAR1 Capital Management02/17 | 5.4%58,000 sh | First report |
| Alyeska Investment Group02/17 | 5.79%61,670 sh | First report |
| Citadel Advisors02/17 | 6.5%70,035 sh | −3.5pp |
| Wellington Management Group02/10 | 5.5%58,949 sh | First report |
| Peter David Boone25/11/24 | 6.4%68,184 sh | First report |